These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8651586)

  • 21. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.
    Siitonen SM; Kononen JT; Helin HJ; Rantala IS; Holli KA; Isola JJ
    Am J Clin Pathol; 1996 Apr; 105(4):394-402. PubMed ID: 8604681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
    Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems.
    Leong AS; Sormunen RT; Vinyuvat S; Hamdani RW; Suthipintawong C
    Am J Clin Pathol; 2001 May; 115(5):709-18. PubMed ID: 11345835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays.
    Bae YK; Gong G; Kang J; Lee A; Cho EY; Lee JS; Suh KS; Lee DW
    Am J Surg Pathol; 2012 Dec; 36(12):1817-25. PubMed ID: 23154769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma.
    Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M
    Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.
    Stierer M; Rosen H; Weber R; Hanak H; Spona J; Tüchler H
    Ann Surg; 1993 Jul; 218(1):13-21. PubMed ID: 8328824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early and more advanced unifocal and multifocal breast carcinomas and their molecular phenotypes.
    Tot T
    Clin Breast Cancer; 2011 Aug; 11(4):258-63. PubMed ID: 21729662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Objective quantitative grading. A study of breast ductal hyperplasias and ductal carcinomas in situ.
    Mariuzzi G; Mombello A; Mariuzzi L; Thompson D; Bartels PH
    Ann N Y Acad Sci; 1996 Apr; 784():395-402. PubMed ID: 8651587
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
    Ronay G; Sponsel N; Tulusan AH
    Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
    [No Abstract]   [Full Text] [Related]  

  • 30. [Correlation of the biochemical and histochemical determination of hormone receptors in carcinoma of the breast with the age of the patient, stage and histologic type of the neoplasm].
    Campobasso O; Concina S; Cozzani C; Ribotta M; Di Carlo F; Conti G; Racca S
    Pathologica; 1987; 79(1059-1060):53-9. PubMed ID: 3441412
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients.
    Singh K; Wang Y; Marketkar S; Kalife ET; Steinhoff MM
    Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of HER-2/neu overexpression among Iranian women with breast cancer: true or false?
    Saatee S; Afrakhteh M; Sadrolhefazi B
    Breast J; 2006; 12(5):499-501. PubMed ID: 16958978
    [No Abstract]   [Full Text] [Related]  

  • 33. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metaplastic carcinomas of the breast: a morphological and immunohistochemical study].
    Gauchotte G; Gauchotte E; Bressenot A; Verhaeghe JL; Guillemin F; Leroux A; Genin P
    Ann Pathol; 2011 Feb; 31(1):18-27. PubMed ID: 21349384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer is heterogeneous.
    Guinebretiere JM
    J Clin Oncol; 2009 Jun; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.
    Luqmani YA; Campbell T; Soomro S; Shousha S; Rio MC; Coombes RC
    Br J Cancer; 1993 Apr; 67(4):749-53. PubMed ID: 8385977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sebaceous carcinoma of the breast.
    Varga Z; Kolb SA; Flury R; Burkhard R; Caduff R
    Pathol Int; 2000 Jan; 50(1):63-6. PubMed ID: 10692180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seven-year survey of classical and pleomorphic invasive lobular breast carcinomas in women from southeastern Serbia: Differences in clinicopathological and immunohistochemical features.
    Ilic IR; Djordjevic NP; Randjelovic PJ; Stojanovic NM; Radulovic NS; Ilic RS
    J BUON; 2016; 21(5):1113-1120. PubMed ID: 27837612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases.
    Tóth J; De Sombre ER; Greene GL
    Zentralbl Pathol; 1991; 137(3):227-32. PubMed ID: 1931896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase activity in normal and neoplastic breast.
    Tsao Jl; Zhao Y; Lukas J; Yang X; Shah A; Press M; Shibata D
    Clin Cancer Res; 1997 Apr; 3(4):627-31. PubMed ID: 9815730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.